<!DOCTYPE html>
<!-- saved from url=(0055)http://localhost:8081/outputs/patent_patent_report.html -->
<html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Patent Analysis Report</title>
    <script src="./Caliway_Patent Analysis Report_files/mermaid.min.js"></script>
    <script>
        mermaid.initialize({ startOnLoad: false, securityLevel: 'loose', gantt: { axisFormat: "%Y-%m" } });
    </script>
    <style>
        body { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif; margin: 20px; background-color: #f8f9fa; color: #333; font-size: 14px;}
        h1 { font-size: 2em; color: #f59e0b; text-align: center; }
        h2 { color: #333; border-bottom: 2px solid #f59e0b; padding-bottom: 5px; margin-top: 40px; }
        .container { width: 100%; overflow-x: auto; margin-bottom: 40px; border: 1px solid #e0e0e0; padding: 10px; border-radius: 8px; background-color: #ffffff; }
        table { width: 100%; border-collapse: collapse; margin-top: 10px; background: #ffffff; border: 1px solid #ddd; }
        th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; white-space: nowrap; }
        td.wrap-text { white-space: normal; }
        th { background-color: #f2f2f2; font-weight: bold; }
        tr.category-header > td { background-color: #e9ecef; font-weight: bold; font-size: 1.1em; }
        tr.note-row > td { background-color: #fafafa; }
        a { color: #007bff; text-decoration: none; }
        .controls { display: flex; align-items: center; justify-content: space-between; flex-wrap: wrap; margin-bottom: 15px; }
        .controls h2 { margin: 0; border: none; }
        .controls .button-group button { background-color: #f59e0b; color: white; border: none; padding: 8px 12px; border-radius: 4px; cursor: pointer; font-size: 14px; margin-left: 10px; }
        .controls .button-group button:hover { background-color: #e08e0b; }
        .editable-field, textarea.editable-field {
            border: 1px solid transparent; background-color: transparent; width: 100%;
            padding: 2px; margin: 0; font-size: inherit; font-family: inherit;
            color: inherit; cursor: text; box-sizing: border-box; resize: vertical; overflow: hidden;
        }
        .editable-field:focus, textarea.editable-field:focus {
            border: 1px solid #f59e0b; background-color: #fff; outline: none; box-shadow: 0 0 3px rgba(245, 158, 11, 0.5);
        }
    </style>
</head>
<body>
    <h1>PTAxial™</h1>
    <div class="container"><h2>Timeline</h2><div class="mermaid" data-processed="true"><svg id="mermaid-1757399149179" width="100%" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 1540 796" style="max-width: 1540px;" role="graphics-document document" aria-roledescription="gantt"><style>#mermaid-1757399149179{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#333;}@keyframes edge-animation-frame{from{stroke-dashoffset:0;}}@keyframes dash{to{stroke-dashoffset:0;}}#mermaid-1757399149179 .edge-animation-slow{stroke-dasharray:9,5!important;stroke-dashoffset:900;animation:dash 50s linear infinite;stroke-linecap:round;}#mermaid-1757399149179 .edge-animation-fast{stroke-dasharray:9,5!important;stroke-dashoffset:900;animation:dash 20s linear infinite;stroke-linecap:round;}#mermaid-1757399149179 .error-icon{fill:#552222;}#mermaid-1757399149179 .error-text{fill:#552222;stroke:#552222;}#mermaid-1757399149179 .edge-thickness-normal{stroke-width:1px;}#mermaid-1757399149179 .edge-thickness-thick{stroke-width:3.5px;}#mermaid-1757399149179 .edge-pattern-solid{stroke-dasharray:0;}#mermaid-1757399149179 .edge-thickness-invisible{stroke-width:0;fill:none;}#mermaid-1757399149179 .edge-pattern-dashed{stroke-dasharray:3;}#mermaid-1757399149179 .edge-pattern-dotted{stroke-dasharray:2;}#mermaid-1757399149179 .marker{fill:#333333;stroke:#333333;}#mermaid-1757399149179 .marker.cross{stroke:#333333;}#mermaid-1757399149179 svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#mermaid-1757399149179 p{margin:0;}#mermaid-1757399149179 .mermaid-main-font{font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1757399149179 .exclude-range{fill:#eeeeee;}#mermaid-1757399149179 .section{stroke:none;opacity:0.2;}#mermaid-1757399149179 .section0{fill:rgba(102, 102, 255, 0.49);}#mermaid-1757399149179 .section2{fill:#fff400;}#mermaid-1757399149179 .section1,#mermaid-1757399149179 .section3{fill:white;opacity:0.2;}#mermaid-1757399149179 .sectionTitle0{fill:#333;}#mermaid-1757399149179 .sectionTitle1{fill:#333;}#mermaid-1757399149179 .sectionTitle2{fill:#333;}#mermaid-1757399149179 .sectionTitle3{fill:#333;}#mermaid-1757399149179 .sectionTitle{text-anchor:start;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1757399149179 .grid .tick{stroke:lightgrey;opacity:0.8;shape-rendering:crispEdges;}#mermaid-1757399149179 .grid .tick text{font-family:"trebuchet ms",verdana,arial,sans-serif;fill:#333;}#mermaid-1757399149179 .grid path{stroke-width:0;}#mermaid-1757399149179 .today{fill:none;stroke:red;stroke-width:2px;}#mermaid-1757399149179 .task{stroke-width:2;}#mermaid-1757399149179 .taskText{text-anchor:middle;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1757399149179 .taskTextOutsideRight{fill:black;text-anchor:start;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1757399149179 .taskTextOutsideLeft{fill:black;text-anchor:end;}#mermaid-1757399149179 .task.clickable{cursor:pointer;}#mermaid-1757399149179 .taskText.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#mermaid-1757399149179 .taskTextOutsideLeft.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#mermaid-1757399149179 .taskTextOutsideRight.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#mermaid-1757399149179 .taskText0,#mermaid-1757399149179 .taskText1,#mermaid-1757399149179 .taskText2,#mermaid-1757399149179 .taskText3{fill:white;}#mermaid-1757399149179 .task0,#mermaid-1757399149179 .task1,#mermaid-1757399149179 .task2,#mermaid-1757399149179 .task3{fill:#8a90dd;stroke:#534fbc;}#mermaid-1757399149179 .taskTextOutside0,#mermaid-1757399149179 .taskTextOutside2{fill:black;}#mermaid-1757399149179 .taskTextOutside1,#mermaid-1757399149179 .taskTextOutside3{fill:black;}#mermaid-1757399149179 .active0,#mermaid-1757399149179 .active1,#mermaid-1757399149179 .active2,#mermaid-1757399149179 .active3{fill:#bfc7ff;stroke:#534fbc;}#mermaid-1757399149179 .activeText0,#mermaid-1757399149179 .activeText1,#mermaid-1757399149179 .activeText2,#mermaid-1757399149179 .activeText3{fill:black!important;}#mermaid-1757399149179 .done0,#mermaid-1757399149179 .done1,#mermaid-1757399149179 .done2,#mermaid-1757399149179 .done3{stroke:grey;fill:lightgrey;stroke-width:2;}#mermaid-1757399149179 .doneText0,#mermaid-1757399149179 .doneText1,#mermaid-1757399149179 .doneText2,#mermaid-1757399149179 .doneText3{fill:black!important;}#mermaid-1757399149179 .crit0,#mermaid-1757399149179 .crit1,#mermaid-1757399149179 .crit2,#mermaid-1757399149179 .crit3{stroke:#ff8888;fill:red;stroke-width:2;}#mermaid-1757399149179 .activeCrit0,#mermaid-1757399149179 .activeCrit1,#mermaid-1757399149179 .activeCrit2,#mermaid-1757399149179 .activeCrit3{stroke:#ff8888;fill:#bfc7ff;stroke-width:2;}#mermaid-1757399149179 .doneCrit0,#mermaid-1757399149179 .doneCrit1,#mermaid-1757399149179 .doneCrit2,#mermaid-1757399149179 .doneCrit3{stroke:#ff8888;fill:lightgrey;stroke-width:2;cursor:pointer;shape-rendering:crispEdges;}#mermaid-1757399149179 .milestone{transform:rotate(45deg) scale(0.8,0.8);}#mermaid-1757399149179 .milestoneText{font-style:italic;}#mermaid-1757399149179 .doneCritText0,#mermaid-1757399149179 .doneCritText1,#mermaid-1757399149179 .doneCritText2,#mermaid-1757399149179 .doneCritText3{fill:black!important;}#mermaid-1757399149179 .vert{stroke:navy;}#mermaid-1757399149179 .vertText{font-size:15px;text-anchor:middle;fill:navy!important;}#mermaid-1757399149179 .activeCritText0,#mermaid-1757399149179 .activeCritText1,#mermaid-1757399149179 .activeCritText2,#mermaid-1757399149179 .activeCritText3{fill:black!important;}#mermaid-1757399149179 .titleText{text-anchor:middle;font-size:18px;fill:#333;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1757399149179 :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}</style><g></g><g class="grid" transform="translate(75, 746)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle"><path class="domain" stroke="currentColor" d="M0,-711V0H1390V-711"></path><g class="tick" opacity="1" transform="translate(24,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2026-01</text></g><g class="tick" opacity="1" transform="translate(175,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2028-01</text></g><g class="tick" opacity="1" transform="translate(327,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2030-01</text></g><g class="tick" opacity="1" transform="translate(479,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2032-01</text></g><g class="tick" opacity="1" transform="translate(631,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2034-01</text></g><g class="tick" opacity="1" transform="translate(783,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2036-01</text></g><g class="tick" opacity="1" transform="translate(935,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2038-01</text></g><g class="tick" opacity="1" transform="translate(1087,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2040-01</text></g><g class="tick" opacity="1" transform="translate(1239,0)"><line stroke="currentColor" y2="-711"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2042-01</text></g></g><g><rect x="0" y="720" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="48" width="1502.5" height="24" class="section section0"></rect><rect x="0" y="72" width="1502.5" height="24" class="section section1"></rect><rect x="0" y="96" width="1502.5" height="24" class="section section1"></rect><rect x="0" y="120" width="1502.5" height="24" class="section section1"></rect><rect x="0" y="144" width="1502.5" height="24" class="section section1"></rect><rect x="0" y="192" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="216" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="240" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="264" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="288" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="312" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="336" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="360" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="384" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="408" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="432" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="456" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="480" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="504" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="528" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="552" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="576" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="600" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="624" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="648" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="672" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="696" width="1502.5" height="24" class="section section2"></rect><rect x="0" y="168" width="1502.5" height="24" class="section section1"></rect></g><g><rect id="task29" rx="3" ry="3" x="75" y="722" width="0" height="20" transform-origin="75px 732px" class="task active2 "></rect><rect id="task1" rx="3" ry="3" x="819" y="50" width="1" height="20" transform-origin="819.5px 60px" class="task active0 "></rect><rect id="task2" rx="3" ry="3" x="819" y="74" width="1" height="20" transform-origin="819.5px 84px" class="task active1 "></rect><rect id="task3" rx="3" ry="3" x="821" y="98" width="0" height="20" transform-origin="821px 108px" class="task active1 "></rect><rect id="task4" rx="3" ry="3" x="832" y="122" width="0" height="20" transform-origin="832px 132px" class="task active1 "></rect><rect id="task5" rx="3" ry="3" x="832" y="146" width="0" height="20" transform-origin="832px 156px" class="task active1 "></rect><rect id="task7" rx="3" ry="3" x="832" y="194" width="0" height="20" transform-origin="832px 204px" class="task active2 "></rect><rect id="task8" rx="3" ry="3" x="832" y="218" width="0" height="20" transform-origin="832px 228px" class="task active2 "></rect><rect id="task9" rx="3" ry="3" x="832" y="242" width="0" height="20" transform-origin="832px 252px" class="task active2 "></rect><rect id="task10" rx="3" ry="3" x="837" y="266" width="0" height="20" transform-origin="837px 276px" class="task active2 "></rect><rect id="task11" rx="3" ry="3" x="837" y="290" width="0" height="20" transform-origin="837px 300px" class="task active2 "></rect><rect id="task12" rx="3" ry="3" x="838" y="314" width="0" height="20" transform-origin="838px 324px" class="task active2 "></rect><rect id="task13" rx="3" ry="3" x="907" y="338" width="1" height="20" transform-origin="907.5px 348px" class="task active2 "></rect><rect id="task14" rx="3" ry="3" x="907" y="362" width="1" height="20" transform-origin="907.5px 372px" class="task active2 "></rect><rect id="task15" rx="3" ry="3" x="907" y="386" width="1" height="20" transform-origin="907.5px 396px" class="task active2 "></rect><rect id="task16" rx="3" ry="3" x="907" y="410" width="1" height="20" transform-origin="907.5px 420px" class="task active2 "></rect><rect id="task17" rx="3" ry="3" x="907" y="434" width="1" height="20" transform-origin="907.5px 444px" class="task active2 "></rect><rect id="task18" rx="3" ry="3" x="907" y="458" width="1" height="20" transform-origin="907.5px 468px" class="task active2 "></rect><rect id="task19" rx="3" ry="3" x="945" y="482" width="1" height="20" transform-origin="945.5px 492px" class="task active2 "></rect><rect id="task20" rx="3" ry="3" x="983" y="506" width="1" height="20" transform-origin="983.5px 516px" class="task active2 "></rect><rect id="task21" rx="3" ry="3" x="986" y="530" width="1" height="20" transform-origin="986.5px 540px" class="task active2 "></rect><rect id="task22" rx="3" ry="3" x="1028" y="554" width="0" height="20" transform-origin="1028px 564px" class="task active2 "></rect><rect id="task23" rx="3" ry="3" x="1166" y="578" width="1" height="20" transform-origin="1166.5px 588px" class="task active2 "></rect><rect id="task24" rx="3" ry="3" x="1166" y="602" width="1" height="20" transform-origin="1166.5px 612px" class="task active2 "></rect><rect id="task25" rx="3" ry="3" x="1281" y="626" width="1" height="20" transform-origin="1281.5px 636px" class="task active2 "></rect><rect id="task26" rx="3" ry="3" x="1357" y="650" width="1" height="20" transform-origin="1357.5px 660px" class="task active2 "></rect><rect id="task27" rx="3" ry="3" x="1417" y="674" width="1" height="20" transform-origin="1417.5px 684px" class="task active2 "></rect><rect id="task28" rx="3" ry="3" x="1443" y="698" width="0" height="20" transform-origin="1443px 708px" class="task active2 "></rect><rect id="task6" rx="3" ry="3" x="1464" y="170" width="1" height="20" transform-origin="1464.5px 180px" class="task active1 "></rect><text id="task29-text" font-size="11" x="80" y="735.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-28.242324829101562">Today </text><text id="task1-text" font-size="11" x="825" y="63.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-59.62919616699219">TWI605832B </text><text id="task2-text" font-size="11" x="825" y="87.5" text-height="20" class=" taskTextOutsideRight taskTextOutside1 activeText1 width-59.62919616699219">TWI593420B </text><text id="task3-text" font-size="11" x="826" y="111.5" text-height="20" class=" taskTextOutsideRight taskTextOutside1 activeText1 width-71.97300720214844">CN106177750A </text><text id="task4-text" font-size="11" x="837" y="135.5" text-height="20" class=" taskTextOutsideRight taskTextOutside1 activeText1 width-70.5276870727539">US10537605B2 </text><text id="task5-text" font-size="11" x="837" y="159.5" text-height="20" class=" taskTextOutsideRight taskTextOutside1 activeText1 width-64.36554718017578">EP3187189B1 </text><text id="task7-text" font-size="11" x="837" y="207.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-64.76593780517578">US9987325B2 </text><text id="task8-text" font-size="11" x="837" y="231.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-64.36554718017578">EP3187178B1 </text><text id="task9-text" font-size="11" x="837" y="255.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-71.70933532714844">CN106604724B </text><text id="task10-text" font-size="11" x="842" y="279.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI580427B </text><text id="task11-text" font-size="11" x="842" y="303.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI580422B </text><text id="task12-text" font-size="11" x="843" y="327.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US10537548B2 </text><text id="task13-text" font-size="11" x="913" y="351.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-71.70933532714844">CN115778928B </text><text id="task14-text" font-size="11" x="913" y="375.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI630922B </text><text id="task15-text" font-size="11" x="913" y="399.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-71.70933532714844">CN109069655B </text><text id="task16-text" font-size="11" x="913" y="423.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US10610496B2 </text><text id="task17-text" font-size="11" x="913" y="447.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-71.70933532714844">CN108697668B </text><text id="task18-text" font-size="11" x="913" y="471.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI604859B </text><text id="task19-text" font-size="11" x="951" y="495.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US10226503B2 </text><text id="task20-text" font-size="11" x="989" y="519.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI667044B </text><text id="task21-text" font-size="11" x="992" y="543.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US10716824B2 </text><text id="task22-text" font-size="11" x="1033" y="567.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI676476B </text><text id="task23-text" font-size="11" x="1172" y="591.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US11433034B2 </text><text id="task24-text" font-size="11" x="1172" y="615.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US11318110B2 </text><text id="task25-text" font-size="11" x="1287" y="639.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI790699B </text><text id="task26-text" font-size="11" x="1363" y="663.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.5276870727539">US12357588B2 </text><text id="task27-text" font-size="11" x="1423" y="687.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-59.62919616699219">TWI864754B </text><text id="task28-text" font-size="11" x="1438" y="711.5" text-height="20" class=" taskTextOutsideLeft taskTextOutside2 activeText2">TW202421100A </text><text id="task6-text" font-size="11" x="1459" y="183.5" text-height="20" class=" taskTextOutsideLeft taskTextOutside1 activeText1">CN120227335A </text></g><g><text dy="0em" x="10" y="62" font-size="11" class="sectionTitle sectionTitle0"><tspan alignment-baseline="central" x="10">CBA-539</tspan></text><text dy="0em" x="10" y="134" font-size="11" class="sectionTitle sectionTitle1"><tspan alignment-baseline="central" x="10">Others</tspan></text><text dy="0em" x="10" y="470" font-size="11" class="sectionTitle sectionTitle2"><tspan alignment-baseline="central" x="10">CBL-514</tspan></text></g><g class="today"><line x1="75" x2="75" y1="25" y2="771" class="today" style="stroke:red;stroke-width:2px"></line></g><text x="770" y="25" class="titleText">Patent Expiry Timeline</text></svg></div></div>
    <div class="container">
        <div class="controls">
            <h2>Patent Table</h2>
            <div class="button-group">
                <button onclick="exportSelectedDataToCSV()" title="只匯出打勾的項目，方便分享與局部處理">匯出已勾選項目</button>
                <button onclick="exportFullVersionToCSV()" title="匯出整份報告的當前狀態，作為新版本存檔">匯出完整版本 (另存新檔)</button>
                <button onclick="document.getElementById(&#39;fileInput&#39;).click()">載入資料</button>
                <input type="file" id="fileInput" style="display: none;" onchange="loadDataFromCSV(event)" accept=".csv">
            </div>
        </div>
        <table id="patent-data-table">
            <thead>
                <tr>
                    <th style="width: 40px;"><input type="checkbox" id="select-all-checkbox" title="全選/取消全選"></th>
                    <th style="min-width: 180px;">Patent Number</th>
                    <th style="min-width: 300px;">Title</th>
                    <th style="min-width: 150px;">Category</th>
                    <th style="min-width: 200px;">Technology Tag</th>
                    <th style="min-width: 200px;">Efficacy Tag</th>
                    <th style="min-width: 120px;">Expiry Date</th>
                    <th style="min-width: 120px;">PTA Extension</th>
                </tr>
            </thead>
            <tbody>
<tr class="category-header"><td colspan="8"><strong>CBA-539</strong></td></tr>
        <tr data-patent-number="CN106310117A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN106310117A" target="_blank">CN106310117A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 111px;">用于抑制酪胺酸酶并减少或预防黑色素生成的植物萃取组合物、其医药品及应用Phytoextraction composition used for inhibiting tyrosinase and reducing or preventing melanogenesis and pharmaceuticals and application thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBA-539"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="HYPERPIGMENTATION"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN106310117A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN106310117A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-07-10">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于抑制酪胺酸酶的酵素活性并减少或预防黑色素生成的植物萃取组合物及其医药品及应用，其中该植物萃取组合物含有重量比例为4:1至1:4的姜黄萃取物与白藜芦醇。本发明植物萃取组合物及其医药品可用于预防和治疗淡化皮肤颜色及黑色素沉淀，以使受体局部部位达到皮肤颜色淡化及减少黑色素沉淀的效果。The invention provides a phytoextraction composition used for inhibiting tyrosinase and reducing or preventing melanogenesis and pharmaceuticals and application thereof. The phytoextraction composition comprises curcumin extract and resveratrol according to a weight ratio of (4:1) to (1:4). The phytoextraction composition and the pharmaceuticals thereof disclosed by the invention can be used for preventing, treating and lightening skin color and melanin precipitation, so that the effects of lightening the skin color and reducing the melanin precipitation at local receptor positions are achieved.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">4:1至1:4的姜黄萃取物与白藜芦醇 (pending)</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI605832B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI605832B" target="_blank">TWI605832B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 44px;">用於淡化膚色與減少黑色素的植物萃取組合物及其醫藥品與用途</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBA-539"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="HYPERPIGMENTATION"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-06-29"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI605832B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI605832B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-06-29">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明提供一種可用於抑制酪胺酸酶的酵素活性並減少或預防黑色素生成之植物萃取組合物及其醫藥品，其中該植物萃取組合物含有重量比例為4：1至1：4之薑黃萃取物與白藜蘆醇。本發明植物萃取組合物及其醫藥品可用於預防和治療淡化皮膚顏色及黑色素沉澱，以使受體局部部位達到皮膚顏色淡化及減少黑色素沉澱之效果。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">4:1至1:4的姜黄萃取物与白藜芦醇 (植物萃取）</textarea></td>
        </tr>
    
        <tr data-patent-number="TW202502305A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TW202502305A" target="_blank">TW202502305A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 58px;">用於減少色素沉澱的醫藥組合物PHARMACEUTICAL COMPOSITIONS FOR USE IN REDUCING HYPERPIGMENTATION</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBA-539"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="NME"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="HYPERPIGMENTATION"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TW202502305A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TW202502305A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2024-07-03">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="一種減少個體中色素沉澱之方法，其包含向有需要之個體之皮膚部位投予有效量之醫藥組合物，其中該醫藥組合物包含醫藥學上可接受之載體及二苯乙烯化合物，例如，式(I)化合物（例如，式(I-A)），或其醫藥學上可接受之鹽類。A method for reducing hyperpigmentation in a subject, comprising administering an effective amount of a pharmaceutical composition to a skin site of a subject in need thereof, wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier and a stilbene compound, for example, a compound of Formula (I) ( e.g., Formula (I-A)), or a pharmaceutically acceptable salt thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">二苯乙烯化合物非白藜蘆醇 (NME)</textarea></td>
        </tr>
    <tr class="category-header"><td colspan="8"><strong>CBL-514</strong></td></tr>
        <tr data-patent-number="US20200230102A1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US20200230102A1" target="_blank">US20200230102A1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">COMPOSITION AND MEDICAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Abandoned"></td>
        </tr>
        <tr class="note-row" data-patent-number="US20200230102A1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US20200230102A1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2019-11-18">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Provided is a plant extract composition and a pharmaceutical composition thereof for reducing body weight and body fat, wherein the plant extract composition comprises a green tea extract and a turmeric extract respectively 30 wt % to 75 wt % and 20 wt % to 55 wt % of a total weight of the composition. In diet-induced obesity models, either obesity is induced first or simultaneously with administration, the plant extract composition and a pharmaceutical composition thereof can reduce body weight and body fat more significantly than a single plant extract or commercially available weight loss drugs.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="EP3187178B1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/EP3187178B1" target="_blank">EP3187178B1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">COMPOSITION AND PHARMACEUTICALS FOR REDUCING LOCALIZED FAT AND BODY WEIGHT AND THE USE THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="MOU"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-08-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="EP3187178B1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="EP3187178B1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Abstract not available for EP3187178B1Abstract of corresponding document: EP3811935A1 Disclosed in the present invention is the composition for reducing local fat and body weight, and pharmaceuticals and use thereof. The composition contains resveratrol and curcumin extract at a weight ration from 1:30 to 10:1. The composition and pharmaceuticals thereof of the invention can inhibit the growth of fat cells, cause planned apoptosis of fat cells, achieve the effects of reducing fat cells, and reducing local fat deposition and body weight without causing inflammations or necrosis of surrounding cells or tissues and inflammations or pain reactions of surrounding tissues, thereby avoiding the problems of tissue damage and inflammatory pains caused by liposuction or low invasion fat-dissolving apparatus used in the prior art and the problems such as surrounding tissue inflammations and necrosis infections triggered by cell disruption and necrosis caused by components of a fat-dissolving injection, phosphatidylcholine or sodium deoxycholate.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">a weight ratio of resveratrol to curcumin ranging from 1:30 to 10:1
Non-therapeutic use </textarea></td>
        </tr>
    
        <tr data-patent-number="US10537548B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10537548B2" target="_blank">US10537548B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Composition and medical product for reducing body weight and body fat, and use of said product</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-09-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10537548B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10537548B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2018-03-27">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention discloses a composition and its pharmaceutical composition for reducing body weight and body fat, and a use of said product The composition comprises epigallocatechin gallate, curcumin, and an excipient, wherein the excipient comprises at least one of glyceryl dibehenate, polyoxyethylene stearates, polysorbate 80 mixture, vitamin E polyethylene glycol succinate, glyceryl monostearate, and oleoyl polyoxyl-6 glycerides, or a combination thereof; the polysorbate 80 mixture comprises polysorbate 80 and magnesium aluminometasilicate. In animal testing where obesity is induced either prior to or during testing, use of the composition of the present invention leads to a significant reduction of body weight and body fat.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;"> and wherein the excipient is selected from the group consisting of glyceryl dibehenate, polyoxyethylene stearates, a polysorbate 80 mixture, wherein the polysorbate 80 mixture comprises polysorbate 80 and aluminometasilicate, vitamin E polyethylene glycol succinate, oleoyl polyoxyl-6 glycerides, and a combination thereof.</textarea></td>
        </tr>
    
        <tr data-patent-number="US12357588B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US12357588B2" target="_blank">US12357588B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Pharmaceutical composition for reducing local fat and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micell composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2042-07-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="US12357588B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US12357588B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2022-07-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention provides a pharmaceutical composition for reducing localized fat, comprising drug-containing micelles made of surfactants, and curcumin encapsulated in said drug-containing micelles. This pharmaceutical composition for reducing localized fat can reduce the fat at the administration site, and has the advantages of high stability, high bioavailability for fat tissue, few side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="US11318110B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11318110B2" target="_blank">US11318110B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Pharmaceutical composition for reducing local fat and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2040-01-22"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11318110B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11318110B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2020-01-22">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention provides a pharmaceutical composition for reducing localized fat, comprising drug-containing micelles made of surfactants, and curcumin encapsulated in said drug-containing micelles. This pharmaceutical composition for reducing localized fat can reduce the fat at the administration site, and has the advantages of high stability, high bioavailability for fat tissue, few side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="US11433034B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11433034B2" target="_blank">US11433034B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Pharmaceutical composition for reducing local fat and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle compostion"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Reducing subcutaneous fat "></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2040-01-22"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11433034B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11433034B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2020-01-22">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention provides a pharmaceutical composition for reducing localized fat, comprising drug-containing micelles made of surfactants, and curcumin encapsulated in said drug-containing micelles. This pharmaceutical composition for reducing localized fat can reduce the fat at the administration site, and has the advantages of high stability, high bioavailability for fat tissue, few side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="US10610496B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10610496B2" target="_blank">US10610496B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Pharmaceutical composition for reducing local fat and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2036-08-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10610496B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10610496B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention provides a pharmaceutical composition for reducing localized fat, comprising drug-containing micelles made of surfactants, and curcumin encapsulated in said drug-containing micelles. This pharmaceutical composition for reducing localized fat can reduce the fat at the administration site, and has the advantages of high stability, high bioavailability for fat tissue, few side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">the curcumin to the polyoxyethylene castor oil derivative is 1:8˜1:500</textarea></td>
        </tr>
    
        <tr data-patent-number="US9987325B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9987325B2" target="_blank">US9987325B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Plant extract composition for reducing localized fat and promoting weight loss as well as application thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="curcumin composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="weight reduction"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-08-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9987325B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9987325B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Provided is a composition and a pharmaceutical composition for reducing localized fat or promoting weight loss, wherein the composition comprises a plant extract composition comprising resveratrol and turmeric extract and a weight ratio of resveratrol and turmeric extract ranges from 1:30 to 10:1. The composition and the pharmaceutical composition are primarily administered through localized injection to inhibit the growth of fat cells and promote fat cells apoptosis to reduce adipocytes, decrease localized fat deposition, and promote weight loss, without causing inflammation or necrosis on peripheral cells or tissues to avoid severe pain, so as to avoid inflammation, damage, and pain caused by surgical liposuction or non-surgical lipolysis products such as phosphatidylcholine and sodium deoxycholate.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">weight ratio of resveratrol to curcumin ranges from 1:30 to 9:1</textarea></td>
        </tr>
    
        <tr data-patent-number="US10226503B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10226503B2" target="_blank">US10226503B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="curcumin composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="weight reduction"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2037-02-23"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10226503B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10226503B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-02-23">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Disclosed in the present invention is the composition for reducing local fat and body weight, and pharmaceuticals and use thereof. The composition contains resveratrol and curcumin extract at a weight ration from 1:30 to 10:1. The composition and pharmaceuticals thereof of the invention can inhibit the growth of fat cells, cause planned apoptosis of fat cells, achieve the effects of reducing fat cells, and reducing local fat deposition and body weight without causing inflammations or necrosis of surrounding cells or tissues and inflammations or pain reactions of surrounding tissues, thereby avoiding the problems of tissue damage and inflammatory pains caused by liposuction or low invasion fat-dissolving apparatus used in the prior art and the problems such as surrounding tissue inflammations and necrosis infections triggered by cell disruption and necrosis caused by components of a fat-dissolving injection, phosphatidylcholine or sodium deoxycholate.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">weight ratio of resveratrol to curcumin ranges from 1:30 to 9:1</textarea></td>
        </tr>
    
        <tr data-patent-number="US20200338152A1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US20200338152A1" target="_blank">US20200338152A1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">SUBCUTANEOUS INJECTION FORMULATION FOR REDUCING BODY WEIGHT AND USES THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Abandoned"></td>
        </tr>
        <tr class="note-row" data-patent-number="US20200338152A1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US20200338152A1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2020-07-10">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention provides a subcutaneous injection formulation for reducing body weight. The subcutaneous injection formulation for reducing body weight comprises drug-containing micelles made of a polyoxyethylene castor oil derivative or polyoxyethylene castor oil derivatives, and a curcuminoid or curcuminoids encapsulated in the drug-containing micelles. The subcutaneous injection formulation for reducing body weight can reduce body weight and visceral fat on overweight or obese subjects, and has the advantages of low dosage, high stability, high fat tissue bioavailability, few side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="US10716824B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10716824B2" target="_blank">US10716824B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Subcutaneous injection formulation for reducing body weight and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="MIcelle Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="weight reduction"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2037-09-10"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10716824B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10716824B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-08-25">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention provides a subcutaneous injection formulation for reducing body weight. The subcutaneous injection formulation for reducing body weight comprises drug-containing micelles made of a polyoxyethylene castor oil derivative or polyoxyethylene castor oil derivatives, and a curcuminoid or curcuminoids encapsulated in the drug-containing micelles. The subcutaneous injection formulation for reducing body weight can reduce body weight and visceral fat on overweight or obese subjects, and has the advantages of low dosage, high stability, high fat tissue bioavailability, few side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI790699B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI790699B" target="_blank">TWI790699B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 58px;">一種包含薑黃素及人蔘皂苷的組合物與應用A COMPOSITION COMPRISING CURCUMIN AND GINSENOSIDE AND USES THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2041-07-29"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI790699B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI790699B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2021-07-29">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明提供一種包含薑黃素及選自Rb1、Rb2、Rc、Rd、Rg1、Rg2、Re、Rf及其他人蔘皂苷的組合物，可用於治療或預防肝臟纖維化、肝臟發炎、肝癌、與肝臟病變，且具有效果好、無毒、無副作用等優點。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="WO2016029868A1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/WO2016029868A1" target="_blank">WO2016029868A1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 78px;">用于减少体重及减少体脂肪的组合物及其医药品与应用COMPOSITION AND MEDICINAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="WO2016029868A1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="WO2016029868A1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明公开一种用于减少体重及减少体脂肪的组合物及其医药品与应用，该组合物包含绿茶萃取物与姜黄萃取物，且以该组合物的总重量为基础，绿茶萃取物与姜黄萃取物的重量百分比分别为30％至75％以及20％至55％。本发明所述的组合物在先诱导肥胖模式的动物试验或同时诱导肥胖的动物试验中，相较于施予单一植物萃取物或市售减肥药物Orlistat，皆具有显著减少体重与体脂肪的效果。A composition and a medicinal product for reducing body weight and body fat, and a use of said product. The composition contains a green tea extract and a turmeric extract, the weight percent of the green tea extract and of the turmeric extract respectively being 30% to 75% and 20% to 55% of the total weight of the composition. In animal testing where obesity is induced either prior to or during testing, use of the composition of the present invention leads to a more significant reduction of body weight and body fat than when using only a plant extract or the commercially available obesity-reducing drug Orlistat.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="WO2018177340A1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/WO2018177340A1" target="_blank">WO2018177340A1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 95px;">用于减少体重及减少体脂肪的组合物及其医药品与应用COMPOSITION FOR REDUCING WEIGHT AND REDUCING BODY FAT AND PHARMACEUTICAL PRODUCT AND APPLICATION THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="WO2018177340A1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="WO2018177340A1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2018-03-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明公开一种用于减少体重及减少体脂肪的组合物及其医药品与应用，该组合物包含表没食子儿茶素没食子酸酯、姜黄素、以及一赋形剂，该赋形剂为甘油二山俞酸酯、聚氧乙烯硬脂酸酯、聚山梨醇酯80混合物、维生素E聚乙二醇琥珀酸酯、单硬脂酸甘油酯、以及油酸聚乙二醇-6甘油酯中的至少一种或其组合；而且，该聚山梨醇酯80混合物包含聚山梨醇酯80以及偏硅酸镁铝。本发明所述的组合物在先诱导肥胖模式的动物试验或同时诱导肥胖的动物试验中，皆具有显著减少体重与体脂肪的效果。The invention discloses a composition for reducing weight and reducing body fat, a pharmaceutical product and an application thereof. The composition comprises epigallocatechin gallate, curcumin, and an excipient. The excipient is at least one or any combination of glyceryl dibehenate, polyoxyethylene stearate, a polysorbate 80 mixture, vitamin E polyethylene glycol succinate, monostearin, and polyethylene glycol-6 glyceryl oleate. In addition, the polysorbate 80 mixture comprises polysorbate 80 and magnesium aluminum metasilicate. The composition of the invention exhibits the effects of significantly reducing weight and body fat both in animal tests in a pre-induced obesity model and in animal tests in a simultaneously-induced obesity model.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN110446492A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN110446492A" target="_blank">CN110446492A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 95px;">用于减少体重及减少体脂肪的组合物及其医药品与应用COMPOSITION FOR REDUCING WEIGHT AND REDUCING BODY FAT AND PHARMACEUTICAL PRODUCT AND APPLICATION THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN110446492A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN110446492A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2018-03-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明公开一种用于减少体重及减少体脂肪的组合物及其医药品与应用，该组合物包含表没食子儿茶素没食子酸酯、姜黄素、以及一赋形剂，该赋形剂为甘油二山俞酸酯、聚氧乙烯硬脂酸酯、聚山梨醇酯80混合物、维生素E聚乙二醇琥珀酸酯、单硬脂酸甘油酯、以及油酸聚乙二醇‑6甘油酯中的至少一种或其组合；而且，该聚山梨醇酯80混合物包含聚山梨醇酯80以及偏硅酸镁铝。本发明所述的组合物在先诱导肥胖模式的动物试验或同时诱导肥胖的动物试验中，皆具有显著减少体重与体脂肪的效果。The invention discloses a composition for reducing weight and reducing body fat, a pharmaceutical product and an application thereof. The composition comprises epigallocatechin gallate, curcumin, andan excipient. The excipient is at least one or any combination of glyceryl dibehenate, polyoxyethylene stearate, a polysorbate 80 mixture, vitamin E polyethylene glycol succinate, monostearin, and polyethylene glycol-6 glyceryl oleate. In addition, the polysorbate 80 mixture comprises polysorbate 80 and magnesium aluminum metasilicate. The composition of the invention exhibits the effects of significantly reducing weight and body fat both in animal tests in a pre-induced obesity model and in animal tests in a simultaneously-induced obesity model.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN106794215A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN106794215A" target="_blank">CN106794215A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 78px;">用于减少体重及减少体脂肪的组合物及其医药品与应用Composition and medicinal product for reducing body weight and body fat, and use of said product</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN106794215A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN106794215A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明公开一种用于减少体重及减少体脂肪的组合物及其医药品与应用，该组合物包含绿茶萃取物与姜黄萃取物，且以该组合物的总重量为基础，绿茶萃取物与姜黄萃取物的重量百分比分别为30％至75％以及20％至55％。本发明所述的组合物在先诱导肥胖模式的动物试验或同时诱导肥胖的动物试验中，相较于施予单一植物萃取物或市售减肥药物Orlistat，皆具有显著减少体重与体脂肪的效果。A composition and a medicinal product for reducing body weight and body fat, and a use of said product. The composition contains a green tea extract and a turmeric extract, the weight percent of the green tea extract and of the turmeric extract respectively being 30% to 75% and 20% to 55% of the total weight of the composition. In animal testing where obesity is induced either prior to or during testing, use of the composition of the present invention leads to a more significant reduction of body weight and body fat than when using only a plant extract or the commercially available obesity-reducing drug Orlistat.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN106604724B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN106604724B" target="_blank">CN106604724B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 44px;">用于减少局部脂肪与减少体重的组合物及其医药品与应用</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-08-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN106604724B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN106604724B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明公开一种用于减少局部脂肪与减少体重的组合物及其医药品与应用，所述组合物包括重量比为1∶30至10∶1的白藜芦醇与姜黄萃取物，本发明所述的组合物及其医药品可抑制脂肪细胞生长，并造成脂肪细胞计划性的凋亡，达到减少脂肪细胞、减少局部脂肪堆积及减少体重的效果，而不会引起周边细胞与组织的发炎反应或组织坏死，亦无外围组织的炎症或疼痛反应，进而避免现有技术利用抽脂手术或低侵入的溶脂仪器所造成的组织受损与发炎疼痛问题，也不会有溶脂注射剂成分磷脂胆碱(phosphatidylcholine)或是脱氧胆酸钠(sodium deoxycholate)造成细胞崩解坏死(necrosis)所引发的外围组织发炎与坏死感染等问题。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">1∶30至9∶1的白藜芦醇与姜黄素</textarea></td>
        </tr>
    
        <tr data-patent-number="WO2016029870A1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/WO2016029870A1" target="_blank">WO2016029870A1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 78px;">用于减少局部脂肪与减少体重的组合物及其医药品与应用COMPOSITION FOR REDUCING LOCAL FAT AND BODY WEIGHT, AND PHARMACEUTICALS AND USE THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="WO2016029870A1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="WO2016029870A1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明公开一种用于减少局部脂肪与减少体重的组合物及其医药品与应用，所述组合物包括重量比为1∶30至10∶1的白藜芦醇与姜黄萃取物，本发明所述的组合物及其医药品可抑制脂肪细胞生长，并造成脂肪细胞计划性的凋亡，达到减少脂肪细胞、减少局部脂肪堆积及减少体重的效果，而不会引起周边细胞与组织的发炎反应或组织坏死，亦无外围组织的炎症或疼痛反应，进而避免现有技术利用抽脂手术或低侵入的溶脂仪器所造成的组织受损与发炎疼痛问题，也不会有溶脂注射剂成分磷脂胆碱（phosphatidylcholine）或是脱氧胆酸钠（sodium deoxycholate）造成细胞崩解坏死（necrosis）所引发的外围组织发炎与坏死感染等问题。Disclosed in the present invention is the composition for reducing local fat and body weight, and pharmaceuticals and use thereof. The composition contains resveratrol and curcumin extract at a weight ratio from 1:30 to 10:1. The composition and pharmaceuticals thereof of the invention can inhibit the growth of fat cells, cause planned apoptosis of fat cells, achieve the effects of reducing fat cells, and reducing local fat deposition and body weight without causing inflammations or necrosis of peripheral cells or tissues and inflammations or pain reactions of peripheral tissues, thereby avoiding the problems of tissue damage and inflammatory pains caused by liposuction or low invasion fat-dissolving apparatus used in the prior art and the problems such as peripheral tissue inflammations and necrosis infections triggered by cell disruption and necrosis caused by components of a fat-dissolving injection, phosphatidylcholine or sodium deoxycholate.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN109069655B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN109069655B" target="_blank">CN109069655B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 24px;">用于减少局部脂肪的医药组成物及其用途</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2036-08-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN109069655B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN109069655B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪的医药组成物，包含医药上可接受的水溶液、表面活性剂所形成的多个含药微胞、以及被包覆在所述含药微胞中的白藜芦醇。所述用于减少局部脂肪的医药组成物可减少施用部位的脂肪，且具有高稳定性、高度脂肪组织生体可用率、低副作用、以及缓释等优点。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN108697668B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN108697668B" target="_blank">CN108697668B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 24px;">用于减少局部脂肪的医药组成物及其用途</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2036-08-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN108697668B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN108697668B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪的医药组成物，包含表面活性剂所形成的多个含药微胞、以及被包覆在所述含药微胞中的姜黄素。所述用于减少局部脂肪的医药组成物可减少施用部位的脂肪，且具有高稳定性、高度脂肪组织生体可用率、低副作用、以及缓释等优点。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN115778928B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN115778928B" target="_blank">CN115778928B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 24px;">用于减少局部脂肪的医药组成物及其用途</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micell composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2036-08-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN115778928B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN115778928B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪的医药组成物，包含表面活性剂所形成的多个含药微胞、以及被包覆在所述含药微胞中的姜黄素。所述用于减少局部脂肪的医药组成物可减少施用部位的脂肪，且具有高稳定性、高度脂肪组织生体可用率、低副作用、以及缓释等优点。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 64px;">其中，该第一多个含药微胞为第一非离子性表面活性剂所形成的第一微形结构，该第一非离子性表面活性剂的亲水亲油性平衡(HLB)值大于10；其中
该第一非离子性表面活性剂包括聚氧乙烯35蓖麻油、聚氧乙烯40氢化蓖麻油或其组合，该姜黄色素类物质与该第一非离子性表面活性剂的重量比为1：8至1：500；或者
该第一非离子性表面活性剂是聚乙二醇15-羟基硬脂酸酯，该姜黄色素类物质与该第一非离子性表面活性剂的重量比为1：40。</textarea></td>
        </tr>
    
        <tr data-patent-number="WO2017037594A2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/WO2017037594A2" target="_blank">WO2017037594A2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 75px;">用于减少局部脂肪的医药组成物及其用途PHARMACEUTICAL COMPOSITION USED FOR REDUCING LOCALISED FAT AND USE OF PHARMACEUTICAL COMPOSITION</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="WO2017037594A2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="WO2017037594A2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪的医药组成物，包含表面活性剂所形成的多个含药微胞、以及被包覆在所述含药微胞中的姜黄素。所述用于减少局部脂肪的医药组成物可减少施用部位的脂肪，且具有高稳定性、高度脂肪组织生体可用率、低副作用、以及缓释等优点。Provided is a pharmaceutical composition used for reducing localised fat, said pharmaceutical composition including a plurality of drug-containing micelles formed by a surfactant, and curcumin coated within the drug-containing micelles. The pharmaceutical composition used for reducing localised fat reduces fat at the site of administration, and has advantages such as high stability, high fat tissue bioavailability, low side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="WO2017037593A2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/WO2017037593A2" target="_blank">WO2017037593A2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 75px;">用于减少局部脂肪的医药组成物及其用途PHARMACEUTICAL COMPOSITION USED FOR REDUCING LOCALISED FAT AND USE OF PHARMACEUTICAL COMPOSITION</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="WO2017037593A2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="WO2017037593A2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪的医药组成物，包含医药上可接受的水溶液、表面活性剂所形成的多个含药微胞、以及被包覆在所述含药微胞中的白藜芦醇。所述用于减少局部脂肪的医药组成物可减少施用部位的脂肪，且具有高稳定性、高度脂肪组织生体可用率、低副作用、以及缓释等优点。Provided is a pharmaceutical composition used for reducing localised fat, said pharmaceutical composition including a pharmaceutically acceptable aqueous solution, a plurality of drug-containing micelles formed by a surfactant, and resveratrol coated within the drug-containing micelles. The pharmaceutical composition used for reducing localised fat reduces fat at the site of administration, and has advantages such as high stability, high fat tissue bioavailability, low side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN119157850A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN119157850A" target="_blank">CN119157850A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 58px;">用于减少局部脂肪的医药组成物及其用途Pharmaceutical composition for reducing local fat and use thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN119157850A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN119157850A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪的医药组成物，包含医药上可接受的水溶液、表面活性剂所形成的多个含药微胞、以及被包覆在所述含药微胞中的白藜芦醇。所述用于减少局部脂肪的医药组成物可减少施用部位的脂肪，且具有高稳定性、高度脂肪组织生体可用率、低副作用、以及缓释等优点。The invention provides a pharmaceutical composition for reducing local fat. The pharmaceutical composition comprises a pharmaceutically acceptable aqueous solution, a plurality of drug-containing micelles formed by a surfactant, and resveratrol coated in the drug-containing micelles. The pharmaceutical composition for reducing local fat can reduce fat at an application site, and has the advantages of high stability, high adipose tissue living body availability, low side effect, slow release and the like.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN120225184A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN120225184A" target="_blank">CN120225184A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 44px;">用于治疗和/或预防水肿性纤维硬化性脂膜病的方法</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Cellulite"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN120225184A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN120225184A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2023-09-13">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本公开提供了一种用于治疗和/或预防有需要的受试者的水肿性纤维硬化性脂膜病(EFP)的方法。所述方法包括向所述受试者施用有效量的药物组合物。所述药物组合物包括多个两亲性纳米颗粒，所述多个两亲性纳米颗粒具有包封在其中的一种或多种活性成分。所述两亲性纳米颗粒中的每个两亲性纳米颗粒由非离子表面活性剂、聚合物载体或脂质载体形成。所述非离子表面活性剂的亲水性‑亲脂性平衡(HLB)值大于9。所述药物组合物是通过以注射、微针或植入物形式实现的肠胃外途径施用的，或通过局部施用或透皮施用来施用的。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="WO2018037384A1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/WO2018037384A1" target="_blank">WO2018037384A1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 75px;">用于減少体重的皮下注射剂及其用途SUBCUTANEOUS INJECTION FOR REDUCING BODY WEIGHT AND APPLICATION THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="WO2018037384A1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="WO2018037384A1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-08-25">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少体重的皮下注射剂，包含聚氧乙烯蓖麻油衍生物所形成的多个含药微胞、以及被包覆在所述含药微胞中的姜黄色素类物质。所述用于减少体重的皮下注射剂可减少过重或肥胖个体的体重及内脏脂肪，且具有剂量低、高稳定性、高度脂肪组织生物利用率、低副作用、以及缓释等优点。Provided is a subcutaneous injection for reducing body weight, comprising a plurality of drug-containing micelles formed of a polyoxyethylene castor oil derivative and curcumin substances encapsulated within said drug-containing micelles. The subcutaneous injection used for reducing body weight reduces body weight and visceral fat of overweight or obese individuals, and has advantages such as low injection volume, high stability, high fat tissue bioavailability, low side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN109640969A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN109640969A" target="_blank">CN109640969A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 58px;">用于減少体重的皮下注射剂及其用途Subcutaneous injection for reducing body weight and application thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN109640969A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN109640969A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-08-25">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少体重的皮下注射剂，包含聚氧乙烯蓖麻油衍生物所形成的多个含药微胞、以及被包覆在所述含药微胞中的姜黄色素类物质。所述用于减少体重的皮下注射剂可减少过重或肥胖个体的体重及内脏脂肪，且具有剂量低、高稳定性、高度脂肪组织生物利用率、低副作用、以及缓释等优点。Provided is a subcutaneous injection for reducing body weight, comprising a plurality of drug-containing micelles formed of a polyoxyethylene castor oil derivative and curcumin substances encapsulatedwithin said drug-containing micelles. The subcutaneous injection used for reducing body weight reduces body weight and visceral fat of overweight or obese individuals, and has advantages such as lowinjection volume, high stability, high fat tissue bioavailability, low side effects, and sustained release.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN119173257A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN119173257A" target="_blank">CN119173257A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 95px;">用于缓解由脂肪组织或脂肪的异常皮下沉积引起的病状的组合物和方法Compositions and methods for alleviating conditions caused by abnormal subcutaneous deposition of adipose tissue or fat</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Dercum’s Disease"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN119173257A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN119173257A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2023-05-15">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="用于缓解由有需要的受试者的脂肪组织或脂肪的异常皮下沉积引起的病状的方法有效量的组合物，所述组合物包括第一活性剂，所述第一活性剂包括(i)白藜芦醇化合物、姜黄素化合物、槲皮素化合物、葛根素化合物或其组合，以及(ii)药学上可接受的载体。A composition for use in a method of alleviating a condition caused by aberrant subcutaneous deposition of adipose tissue or fat in a subject in need thereof, the composition comprising a first active agent comprising (i) a resveratrol compound, a curcumin compound, a quercetin compound, a puerarin compound, or a combination thereof, and (ii) a pharmaceutically acceptable carrier.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI604859B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI604859B" target="_blank">TWI604859B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 58px;">用於減少局部脂肪的醫藥組成物及其用途A PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2036-08-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI604859B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI604859B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明提供一種用於減少局部脂肪的醫藥組成物，包含醫藥上可接受之水溶液、界面活性劑所形成的複數個含藥微胞、以及被包覆在所述含藥微胞中的白藜蘆醇。所述用於減少局部脂肪的醫藥組成物可減少施用部位的脂肪，且具有高安定性、高度脂肪組織生體可用率、低副作用、以及緩釋等優點。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI630922B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI630922B" target="_blank">TWI630922B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 58px;">用於減少局部脂肪的醫藥組成物及其用途A PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Micelle composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2036-08-26"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI630922B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI630922B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-26">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明提供一種用於減少局部脂肪的醫藥組成物，包含界面活性劑所形成的複數個含藥微胞、以及被包覆在所述含藥微胞中的薑黃素。所述用於減少局部脂肪的醫藥組成物可減少施用部位的脂肪，且具有高安定性、高度脂肪組織生體可用率、低副作用、以及緩釋等優點。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI580422B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI580422B" target="_blank">TWI580422B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 44px;">用於減少局部脂肪與減少體重的組合物及其醫藥品與應用</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="local site"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-09-21"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI580422B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI580422B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-09-21">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明公開一種用於減少局部脂肪與減少體重的組合物及其醫藥品與用途，其包括重量比為1：30至10：1的白藜蘆醇與薑黃萃取物，本發明所述的組合物及其醫藥品可抑制脂肪細胞生長，並造成脂肪細胞計畫性的凋亡，達到減少脂肪細胞、減少局部脂肪堆積及減少體重的效果，而不會引起周邊細胞與組織的發炎反應或組織壞死，亦無週邊組織的炎症或疼痛反應，進而避免現有技術利用抽脂手術或低侵入的溶脂儀器所造成的組織受損與發炎疼痛問題，也不會有溶脂注射劑成份磷脂膽鹼(phosphatidylcholine)或是脫氧膽酸鈉(sodium deoxycholate)造成細胞崩解壞死(necrosis)所引發的週邊組織發炎與壞死感染等問題。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">1：30至10：1的白藜蘆醇與薑黃萃取物。</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI580427B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI580427B" target="_blank">TWI580427B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 44px;">用於減少體重及減少體脂肪的組合物及其醫藥品與應用</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-09-21"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI580427B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI580427B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-09-21">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明公開一種用於減少體重與體脂肪的植物萃取組合物及其醫藥品與用途，其植物萃取組合物包含綠茶萃取物與薑黃萃取物，且以植物萃取組合物的總重量為基礎，綠茶萃取物與薑黃萃取物的重量百分比分別為30%至75%以及20%至55%。本發明所述的植物萃取組合物在先誘導肥胖模式的動物試驗或同時誘導肥胖的動物試驗中，相較於施予單一植物萃取物或市售減肥藥物Orlistat，皆具有顯著減少體重與體脂肪的效果。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">該組合物包括重量比為1：30至10：1的白藜蘆醇與薑黃萃取物</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI676476B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI676476B" target="_blank">TWI676476B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 78px;">用於減少體重及減少體脂肪的組合物及其醫藥品與應用COMPOSITION AND MEDICAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2038-03-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI676476B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI676476B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2018-03-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明公開一種用於減少體重及減少體脂肪的組合物及其醫藥品與應用，該組合物包含表沒食子兒茶素沒食子酸酯、薑黃素、以及一賦形劑，該賦形劑為甘油二山俞酸酯、聚氧乙烯硬脂酸酯、聚山梨醇酯80混合物、維生素E聚乙二醇琥珀酸酯、單硬脂酸甘油酯、以及油酸聚乙二醇-6甘油酯中之至少一者或其組合；而且，該聚山梨醇酯80混合物包含聚山梨醇酯80以及偏矽酸鎂鋁。本發明所述的組合物在先誘導肥胖模式的動物試驗或同時誘導肥胖的動物試驗中，皆具有顯著減少體重與體脂肪的效果。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI667044B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI667044B" target="_blank">TWI667044B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 75px;">用於減少體重的皮下注射劑及其用途A SUBCUTANEOUS INJECTION FORMULATION FOR REDUCING BODY WEIGHT AND USES THEREOF</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Composition"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2037-08-24"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI667044B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI667044B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-08-24">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明提供一種用於減少體重的皮下注射劑，包含聚氧乙烯蓖麻油衍生物所形成的複數個含藥微胞、以及被包覆在所述含藥微胞中的薑黃色素類物質。所述用於減少體重的皮下注射劑可減少過重或肥胖個體的體重及內臟脂肪，且具有劑量低、高安定性、高度脂肪組織生體可用率、低副作用、以及緩釋等優點。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TW202508551A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TW202508551A" target="_blank">TW202508551A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 95px;">用於緩解由脂肪組織或脂肪的異常皮下沉積所引起的病狀之組合物及方法COMPOSITIONS AND METHODS FOR ALLEVIATING CONDITIONS CAUSED BY ABNORMAL SUBCUTANEOUS DEPOSIT OF ADIPOSE TISSUE OR FAT</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Dercum’s Disease"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value=""></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TW202508551A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TW202508551A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2023-05-15">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="用於緩解一有需要的個體中脂肪組織或脂肪的異常皮下沉積所引起的病狀之方法，該方法係關於含有一第一活性劑之有效劑量的組合物，第一活性劑包含(i)白藜蘆醇化合物、薑黃素化合物、槲皮素化合物、葛根素化合物，或其組合，以及(ii)一醫藥學上可接受的載體。Methods for alleviating a condition caused by abnormal subcutaneous deposit of adipose tissue or fat in a subject in need thereof an effective amount of a composition comprising a first active agent, which comprises (i) a resveratrol compound, a curcumin compound, a quercetin compound, a puerarin compound, or a combination thereof, and (ii) a pharmaceutically acceptable carrier.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI864754B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI864754B" target="_blank">TWI864754B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 95px;">用於緩解由脂肪組織或脂肪的異常皮下沉積所引起的病狀之組合物及方法COMPOSITIONS AND METHODS FOR ALLEVIATING CONDITIONS CAUSED BY ABNORMAL SUBCUTANEOUS DEPOSIT OF ADIPOSE TISSUE OR FAT</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Dercum’s Disease"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2043-05-15"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI864754B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI864754B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2023-05-15">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿用於緩解一有需要的個體中脂肪組織或脂肪的異常皮下沉積所引起的病狀之方法，該方法係關於含有一第一活性劑之有效劑量的組合物，第一活性劑包含(i)白藥蘆醇化合物、薑黃素化合物、槲皮素化合物、葛根素化合物，或其組合，以及(ii)一醫藥學上可接受的載體。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 41px;">一種組合物之用途，其係用於製備緩解一個體中脂肪瘤或脂肪塊所引起的疼痛的注射劑，且該注射劑係施用於病灶的注射劑；其中，該組合物包含一第一活性劑，該第一活性劑包含(i)薑黃素，以及(ii)一醫藥學上可接受的載體。
</textarea></td>
        </tr>
    
        <tr data-patent-number="TW202421100A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TW202421100A" target="_blank">TW202421100A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 111px;">醫藥組合物用於製備治療和／或預防水腫性纖維硬化性脂膜病的藥物之用途METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="CBL-514"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Cellulite"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2043-09-13"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TW202421100A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TW202421100A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2023-09-13">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本發明提供一種治療和/或預防個體的水腫性纖維硬化性脂膜病之用途，此方法具有施用一有效量的醫藥組合物於個體之步驟，此醫藥組合物具有複數個兩親性奈米粒子，其中包覆了一種或多種的活性成分，每一兩親性奈米粒子是由非離子界面活性劑、聚合載體、或脂質載體所形成，且非離子界面活性劑的親水親油性平衡值(HLB)大於9。醫藥組合物是經由以注射劑、微針或植入劑的非消化道給藥途徑，或經由局部給藥途徑或經皮給藥途徑被施用。The present disclosure provides a method for treating and/or preventing edematous fibrosclerotic panniculopathy (EFP) in a subject in need thereof. The method includes administering an effective amount of a pharmaceutical composition to the subject. The pharmaceutical composition includes a plurality of amphiphilic nanoparticles having one or more active ingredients encapsulated therein. Each of the amphiphilic nanoparticles is formed by a non-ionic surfactant, a polymeric carrier, or a lipid carrier. The hydrophilic-lipophilic balance (HLB) value of the non-ionic surfactant is greater than 9. The pharmaceutical composition is administered via a parenteral route by an injection, a microneedle, or an implant, or via topical administration or transdermal administration.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    <tr class="category-header"><td colspan="8"><strong>Others</strong></td></tr>
        <tr data-patent-number="EP3187189B1">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/EP3187189B1" target="_blank">EP3187189B1</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">COMPOSITION FOR USE IN TREATING OBESITY AND USE OF SAID COMPOSITION FOR REDUCING BODY WEIGHT AND FAT</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Others"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-08-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="EP3187189B1">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="EP3187189B1">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Abstract not available for EP3187189B1Abstract of corresponding document: EP3187189A1 A composition and a medicinal product for reducing body weight and body fat, and a use of said product. The composition contains a green tea extract and a turmeric extract, the weight percent of the green tea extract and of the turmeric extract respectively being 30% to 75% and 20% to 55% of the total weight of the composition. In animal testing where obesity is induced either prior to or during testing, use of the composition of the present invention leads to a more significant reduction of body weight and body fat than when using only a plant extract or the commercially available obesity-reducing drug Orlistat.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;"> a green tea extract and a turmeric extract</textarea></td>
        </tr>
    
        <tr data-patent-number="US10537605B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10537605B2" target="_blank">US10537605B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Composition of plant extract and its pharmaceutical composition and application thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Others"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-08-28"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10537605B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10537605B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-08-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Provided is a plant extract composition and a pharmaceutical composition thereof for reducing body weight and body fat, wherein the plant extract composition comprises a green tea extract and a turmeric extract respectively 30 wt % to 75 wt % and 20 wt % to 55 wt % of a total weight of the composition. In diet-induced obesity models, either obesity is induced first or simultaneously with administration, the plant extract composition and a pharmaceutical composition thereof can reduce body weight and body fat more significantly than a single plant extract or commercially available weight loss drugs.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN120227335A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN120227335A" target="_blank">CN120227335A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 24px;">一种脂质体复合物及其用途</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Others"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2043-12-27"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN120227335A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN120227335A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2023-12-27">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明提供一种用于减少局部脂肪、减少体重、预防和治疗淡化皮肤颜色及黑色素沉淀、及减缓关节炎症状之组合物与相关方法。该组合物包含至少一种活性成分及脂质体，且该脂质体用以作为所述活性成分之载体而包覆所述活性成分而形成脂质体复合物。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="CN106177750A">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/CN106177750A" target="_blank">CN106177750A</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 78px;">用于减缓关节炎的组合物及其医药品、制造方法与应用Composition For Alleviating Arthritis, And Pharmaceuticals And Manufacturing Method And Application Thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Others"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-07-06"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="CN106177750A">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="CN106177750A">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-07-06">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="本发明关于一种用于减缓关节炎的组合物及其医药品、制造方法与应用。具体而言，本发明关于一种用于减轻关节炎症的组合物，亦关于一种以前述组合物用于治疗关节炎的用途，该用途包括将有效剂量的所述组合物施予受体；并通过包含特定组分的白藜芦醇、姜黄萃取物与槲皮素的组合物或医药品以达到抑制COX‑2及NF‑κB表达，进而以减少蚀骨细胞增殖以及减缓骨质流失、骨质疏松症及退化性关节炎。The invention provides a composition for alleviating arthritis, and pharmaceuticals and manufacturing method and application thereof. The composition for alleviating arthritis is provided. An application of the composition for treating arthritis is also provided, which applies the composition having an effective dose to an acceptor, and takes a composition or a pharmaceutical including particular components of resveratrol, curcumin extract and quercetin to suppress the expression of COX-2 and NF-[kappa]B, capable of reducing osteoclast proliferation, and alleviating bone loss, osteoporosis and degenerative arthritis.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    
        <tr data-patent-number="TWI593420B">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/TWI593420B" target="_blank">TWI593420B</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 44px;">用於減緩關節炎的組合物及其醫藥品、製造方法與應用</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Others"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="nan"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Others"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2035-06-30"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="TBD"></td>
        </tr>
        <tr class="note-row" data-patent-number="TWI593420B">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="TWI593420B">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-06-30">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="nan">
                <input type="hidden" class="editable-field" data-column="Abstract" value="﻿本發明關於一種用於減輕關節炎症的組合物。本發明亦關於一種以前述組合物用於治療關節炎之用途，該用途包括將所述之有效劑量組合物施予受體；並藉由包含特定組分之白藜蘆醇、薑黃萃取物與槲黃素之組合物或醫藥品以達到抑制COX-2及NF-κB表現，進以減少蝕骨細胞增殖以及減緩骨質流失、骨質疏鬆症及退化性關節炎。">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">nan</textarea></td>
        </tr>
    </tbody></table></div><div class="container"><h2>2-D Matrix: Category vs. Efficacy</h2><table><thead><tr><th>Category / Efficacy</th><th>Cellulite</th><th>Dercum’s Disease</th><th>HYPERPIGMENTATION</th><th>Reducing subcutaneous fat </th><th>local site</th><th>weight reduction</th></tr></thead><tbody><tr><td>CBA-539</td><td></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/CN106310117A" target="_blank">CN106310117A</a>, <a href="https://patents.google.com/patent/TWI605832B" target="_blank">TWI605832B</a>, <a href="https://patents.google.com/patent/TW202502305A" target="_blank">TW202502305A</a></td><td></td><td></td><td></td></tr><tr><td>CBL-514</td><td class="wrap-text"><a href="https://patents.google.com/patent/CN120225184A" target="_blank">CN120225184A</a>, <a href="https://patents.google.com/patent/TW202421100A" target="_blank">TW202421100A</a></td><td class="wrap-text"><a href="https://patents.google.com/patent/CN119173257A" target="_blank">CN119173257A</a>, <a href="https://patents.google.com/patent/TW202508551A" target="_blank">TW202508551A</a>, <a href="https://patents.google.com/patent/TWI864754B" target="_blank">TWI864754B</a></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US11433034B2" target="_blank">US11433034B2</a></td><td class="wrap-text"><a href="https://patents.google.com/patent/EP3187178B1" target="_blank">EP3187178B1</a>, <a href="https://patents.google.com/patent/US12357588B2" target="_blank">US12357588B2</a>, <a href="https://patents.google.com/patent/US10610496B2" target="_blank">US10610496B2</a>, <a href="https://patents.google.com/patent/CN106604724B" target="_blank">CN106604724B</a>, <a href="https://patents.google.com/patent/CN109069655B" target="_blank">CN109069655B</a>, <a href="https://patents.google.com/patent/CN108697668B" target="_blank">CN108697668B</a>, <a href="https://patents.google.com/patent/TWI580422B" target="_blank">TWI580422B</a></td><td class="wrap-text"><a href="https://patents.google.com/patent/US10716824B2" target="_blank">US10716824B2</a>, <a href="https://patents.google.com/patent/US9987325B2" target="_blank">US9987325B2</a>, <a href="https://patents.google.com/patent/US10226503B2" target="_blank">US10226503B2</a></td></tr></tbody></table></div>
    <footer><p>© 2025 Eudaimonia IP Consulting. All rights reserved.</p></footer>
<script>
    // This script block contains all the final, working Javascript functions.
    // (JavaScript is unchanged from the last working version)
    function autoResizeTextarea(element) { element.style.height = 'auto'; element.style.height = (element.scrollHeight) + 'px'; }
    function setupEventListeners() {
        try { mermaid.run({ querySelector: ".mermaid" }); } catch(e) { console.error("Mermaid Error:", e); }
        var selectAllCheckbox = document.getElementById('select-all-checkbox');
        var itemCheckboxes = document.querySelectorAll('#patent-data-table .export-checkbox');
        if(selectAllCheckbox) {
            selectAllCheckbox.addEventListener('change', function() { itemCheckboxes.forEach(function(c) { c.checked = selectAllCheckbox.checked; }); });
        }
        itemCheckboxes.forEach(function(checkbox) {
            checkbox.addEventListener('change', function() {
                if (!checkbox.checked) { selectAllCheckbox.checked = false; }
                else { selectAllCheckbox.checked = Array.from(itemCheckboxes).every(function(cb) { return cb.checked; }); }
            });
        });
        document.querySelectorAll('textarea.editable-field').forEach(function(textarea) {
            textarea.addEventListener('input', function() { autoResizeTextarea(this); });
            autoResizeTextarea(textarea);
        });
    }
    if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', setupEventListeners); } else { setupEventListeners(); }
    function sanitizeCell(cellData) { var data = String(cellData == null ? '' : cellData); if (/[",\r\n]/.test(data)) { return '"' + data.replace(/"/g, '""') + '"'; } return data; }
    function gatherRowData(dataRow) {
        var noteRow = dataRow.nextElementSibling;
        var rowData = {};
        [...dataRow.querySelectorAll('.editable-field'), ...(noteRow ? noteRow.querySelectorAll('.editable-field') : [])].forEach(function(field) {
             rowData[field.dataset.column] = field.value; 
        });
        return rowData;
    }
    function downloadCSV(csvContent, filename) {
        if (!csvContent) { alert("沒有資料可供匯出。"); return; }
        var blob = new Blob(['\uFEFF' + csvContent], { type: 'text/csv;charset=utf-8;' });
        var link = document.createElement("a");
        var url = URL.createObjectURL(blob);
        link.setAttribute("href", url); link.setAttribute("download", filename);
        document.body.appendChild(link); link.click();
        document.body.removeChild(link); URL.revokeObjectURL(url);
    }
    function exportSelectedDataToCSV() {
        var headers = ['Patent Number', 'Title', 'Classification Tag', 'Category', 'Application Date', 'Expiry Date', 'Is Terminal Disclaimer', 'Technology Tag', 'Efficacy Tag', 'Abstract', 'PTA Extension', 'Note'];
        var csvRows = [headers.join(',')];
        var checkedBoxes = document.querySelectorAll('#patent-data-table .export-checkbox:checked');
        if (checkedBoxes.length === 0) { alert("請先勾選您想要匯出的專利項目。"); return; }
        checkedBoxes.forEach(function(checkbox) {
            var dataRow = checkbox.closest('tr');
            var rowData = gatherRowData(dataRow);
            var orderedRow = headers.map(function(header) { return rowData[header] || ""; });
            csvRows.push(orderedRow.map(sanitizeCell).join(','));
        });
        downloadCSV(csvRows.join('\n'), "patent_data_selected.csv");
        alert("成功匯出 " + checkedBoxes.length + " 筆已勾選的專利資料！");
    }
    function exportFullVersionToCSV() {
        var headers = ['Patent Number', 'Title', 'Classification Tag', 'Category', 'Application Date', 'Expiry Date', 'Is Terminal Disclaimer', 'Technology Tag', 'Efficacy Tag', 'Abstract', 'PTA Extension', 'Note'];
        var csvRows = [headers.join(',')];
        var allDataRows = document.querySelectorAll('#patent-data-table > tbody > tr:not(.category-header):not(.note-row)');
        if (allDataRows.length === 0) { alert("表格中沒有找到任何資料可供匯出。"); return; }
        allDataRows.forEach(function(dataRow) {
            var rowData = gatherRowData(dataRow);
            var orderedRow = headers.map(function(header) { return rowData[header] || ""; });
            csvRows.push(orderedRow.map(sanitizeCell).join(','));
        });
        downloadCSV(csvRows.join('\n'), "patent_data_full_version.csv");
        alert("成功匯出 " + allDataRows.length + " 筆完整專利資料！");
    }
    function loadDataFromCSV(event) {
        var file = event.target.files[0]; if (!file) return;
        var reader = new FileReader();
        reader.onload = function(e) {
            var lines = e.target.result.split(/\r?\n/);
            var recordsUpdated = 0;
            var headers = lines[0].split(',').map(function(h) { return h.trim().replace(/"/g, '').toLowerCase(); });
            var patentIdIndex = headers.indexOf('patent number');
            if (patentIdIndex === -1) { alert("CSV 檔案中找不到 'Patent Number' 欄位。"); event.target.value = ''; return; }
            var headerMap = {};
            headers.forEach(function(h, i) { headerMap[h] = i; });
            for (var i = 1; i < lines.length; i++) {
                var line = lines[i]; if (line.trim() === '') continue;
                var columns = line.match(/(".*?"|[^",]+)(?=\s*,|\s*$)/g) || [];
                var patentId = (columns[patentIdIndex] || '').trim().replace(/^"|"$/g, '');
                if (patentId) {
                    var escapedPatentId = patentId.replace(/"/g, '\"');
                    var dataRow = document.querySelector(`tr[data-patent-number="${escapedPatentId}"]`);
                    if(dataRow) {
                        var noteRow = dataRow.nextElementSibling;
                        var fields = [...dataRow.querySelectorAll('.editable-field'), ...(noteRow ? noteRow.querySelectorAll('.editable-field') : [])];
                        fields.forEach(function(field) {
                            var columnKey = field.dataset.column.toLowerCase();
                            var columnIndex = headerMap[columnKey];
                            if (columnIndex !== undefined && columns[columnIndex] !== undefined) {
                                var value = columns[columnIndex].trim().replace(/^"|"$/g, '').replace(/""/g, '"');
                                field.value = value;
                            }
                        });
                        [...dataRow.querySelectorAll('textarea.editable-field'), ...(noteRow ? noteRow.querySelectorAll('textarea.editable-field') : [])].forEach(autoResizeTextarea);
                        recordsUpdated++;
                    }
                }
            }
            alert("處理完成！共更新了 " + recordsUpdated + " 筆專利的資料。");
            event.target.value = '';
        };
        reader.readAsText(file, 'UTF-8');
    }
</script>


</body></html>